Healthcare -
Biotechnology - NASDAQ - US
$ 8.71
-2.21 %
$ 327 M
Market Cap
4.73
P/E
TRDA - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities TRDA - Entrada Therapeutics, Inc.
-27.8 M
LAST VALUE
56.76%
2 YEAR CAGR
-113.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR